NEW YORK (GenomeWeb News) – Micronics today said that it has received a $2.6 million from the US Department of Defense to support development of its PanNAT system for point-of-care molecular diagnostics of infectious pathogens.
Redmond, Wash.-based Micronics is developing the sample-to-answer system for rapid disease detection. It said that the PanNAT system will directly detect multiple blood-borne pathogens, including hepatitis B and C and HIV, in fresh blood samples.
The assays running on the system will be used in the battlefield to screen out any infectious blood donated for transfusion, said Micronics.
The Applied Research and Technology Development Award was granted under the US Army Medical Research and Material Command's Polytrauma and Blast Injury project.